Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/605507 stock hub

SHA/605507 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/605507is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.9B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/605507
In the news

Latest news · SHA/605507

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E16.7
P25 23.5P50 41.3P75 83.2
ROE9
P25 -0.9P50 4.1P75 8.8
ROIC11.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/605507 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
224
Groups with data
11
Currency
CNY
Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
4,251
Employees Change
248%
Employees Change Percent
6.2
Enterprise value
CNY 11.2B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE100004NS2
Last refreshed
2026-05-10
Market cap
CNY 12.9B
Price
CNY 23.16
Price currency
CNY
Rev Per Employee
1,433,126.76x
Sector
Healthcare
Sic
2834
Symbol
sha/605507
Website
https://www.gbgcn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
5.92%
EV Earnings
14.58x
EV/EBIT
12.57x
EV/EBITDA
8.12x
EV/FCF
14.4x
EV/Sales
1.83x
FCF yield
6%
P/B ratio
1.48x
P/E ratio
16.67x
P/S ratio
2.12x
PE Ratio3 Y
15.4x
PE Ratio5 Y
16.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
14.59%
EBITDA Margin
22.6%
FCF margin
12.74%
Gross margin
24.6%
Gross Profit
CNY 1.5B
Gross Profit Growth
3.43%
Gross Profit Growth Q
-7.87%
Gross Profit Growth3 Y
-0.92%
Gross Profit Growth5 Y
-0.76%
Net Income
CNY 766.5M
Net Income Growth
-3.93%
Net Income Growth Q
-25.28%
Net Income Growth Years
2%
Net Income Growth3 Y
-5.74%
Net Income Growth5 Y
-1.67%
Pretax Margin
14.6%
Profit Margin
12.58%
Profit Per Employee
CNY 180,304
Profitable Years
9
ROA
4.94
Roa5y
5.85
ROCE
10.07
ROE
8.99
Roe5y
11.32
ROIC
11.06
Roic5y
14.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
24.78%
Cagr3y
3.09%
Div CAGR3
-4.7%
EPS Growth
-2.18
EPS Growth Q
-23.68
EPS Growth Years
2
EPS Growth3 Y
-5.38
EPS Growth5 Y
-1.41
FCF Growth
671.63%
FCF Growth3 Y
41.22%
OCF Growth
154.49%
OCF Growth3 Y
-1.6%
OCF Growth5 Y
12.52%
Revenue Growth
1.67x
Revenue Growth Q
5.61x
Revenue Growth Quarters
2x
Revenue Growth Years
2x
Revenue Growth3 Y
0.76x
Revenue Growth5 Y
6.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 0.54
Assets
CNY 11.4B
Cash
CNY 2.8B
Current Assets
CNY 6.5B
Current Liabilities
CNY 2.6B
Debt
CNY 994.3M
Debt EBITDA
CNY 0.72
Debt Equity
CNY 0.11
Debt FCF
CNY 1.28
Equity
CNY 8.7B
Interest Coverage
32.33
Liabilities
CNY 2.7B
Long Term Assets
CNY 4.9B
Long Term Liabilities
CNY 109M
Net Cash
CNY 1.8B
Net Cash By Market Cap
CNY 13.68
Net Cash Growth
38.43%
Net Debt EBITDA
CNY -1.29
Net Debt Equity
CNY -0.2
Net Debt FCF
CNY -2.28
Tangible Book Value
CNY 8.4B
Tangible Book Value Per Share
CNY 14.98
WACC
5.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.54
Inventory Turnover
2.89
Net Working Capital
CNY 2.1B
Quick ratio
1.7
Working Capital
CNY 4B
Working Capital Turnover
CNY 1.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
1.79%
Dividend Growth
100.92%
Dividend Growth Years
1%
Dividend per share
CNY 0.6
Dividend Years
5
Dividend Yield
2.59%
Ex Div Date
2025-06-13
Last Dividend
CNY 0.61
Payout Frequency
Annual
Payout Ratio
47.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
24.76%
200-day SMA
24.19
3Y total return
9.55%
50-day SMA
25.86
50-day SMA vs 200-day SMA
50over200
All Time High
47.9
All Time High Change
-51.65%
All Time High Date
2021-08-03
All Time Low
13.01
All Time Low Change
78.02%
All Time Low Date
2024-02-05
ATR
0.65
Beta
0.29
Beta1y
-0.04
Beta2y
0.14
Ch YTD
-6.61
High
23.59
High52
29.98
High52 Date
2026-03-13
High52ch
-22.75%
Low
22.93
Low52
19.04
Low52 Date
2025-05-08
Low52ch
21.64%
Ma50ch
-10.44%
Price vs 200-day SMA
-4.25%
RSI
31.71
RSI Monthly
51.08
RSI Weekly
42.86
Sharpe ratio
0.84x
Sortino ratio
1.55
Total Return
4.38%
Tr YTD
-6.61
Tr1m
-8.96%
Tr1w
-1.61%
Tr3m
-15.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 888.8M
Operating Income Growth
5.91
Operating Income Growth Q
-11.02
Operating Income Growth3 Y
-1.69
Operating Income Growth5 Y
-3.18
Operating margin
14.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
231,534,533%
Net Borrowing
-7,843,539
Shares Insiders
12.66%
Shares Institutions
16.67%
Shares Out
558,823,500
Shares Qo Q
-0.5%
Shares Yo Y
-1.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
CNY 776M
Average Volume
3,886,893.3x
Bv Per Share
15.59
CAPEX
CNY -328.1M
Ch1m
-8.96
Ch1w
-1.61
Ch1y
21.19
Ch3m
-15.51
Ch3y
1.8
Ch6m
1.67
Change
-1.7%
Change From Open
-1.7
Close
23.56
Days Gap
0
Depreciation Amortization
487,855,850
Dollar Volume
122,935,596
Earnings Date
2026-07-30
EBIT
CNY 888.8M
EBITDA
CNY 1.4B
EPS
CNY 1.39
F Score
7
FCF
CNY 776M
FCF EV Yield
6.95x
FCF Per Share
CNY 1.39
Financing CF
-343,359,097
Fiscal Year End
December
Founded
1,996
Goodwill
25,487
Graham Number
22.07868
Graham Upside
-4.67
Income Tax
CNY 126.2M
Investing CF
-782,742,851
Is Primary Listing
1
Last Earnings Date
2026-03-28
Last Report Date
2026-03-31
Lynch Fair Value
CNY 6.95
Lynch Upside
-70
Ma150
24.72
Ma150ch
-6.3%
Ma20
24.42
Ma20ch
-5.17%
Net CF
-36,180,784
Next Earnings Date
2026-07-30
Open
23.56
P FCF Ratio
16.68
P OCF Ratio
11.72
Payment Date
2025-06-13
Position In Range
34.85
Ppne
4,302,898,416
Price Date
2026-05-08
Price EBITDA
CNY 9.4
Ptbv Ratio
1.55
Relative Volume
1.39x
Revenue
6,092,221,838x
Tax By Revenue
2.07x
Tax Rate
14.18%
Tr6m
1.67%
Volume
5,308,100
Z Score
4.61
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/605507 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.6%
$0.60 annual per share
Payout ratio
+47.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+4.4%
Next ex-dividend date: 2025-06-13
Performance

SHA/605507 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+24.8%
S&P 500 1Y: n/a
3Y total return
+9.6%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/605507?

Insider, institutional, and short-interest positioning.

Institutional ownership
+16.7%
Share of float held by funds and institutions
Insider ownership
+12.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.8%
Negative means the company is buying back shares.
Technical

SHA/605507 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
31.7
Neutral momentum band
Price vs 200-day MA
-4.2%
50/200-day relationship not available
Beta (5Y)
0.29
Less volatile than the market
Sharpe ratio
0.84
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/605507

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/605507 stock rating?

sha/605507 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/605507 analysis?

The full report lives at /stocks/sha/605507/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/605507?

The latest report frames sha/605507 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/605507 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/605507 stock profile: metrics, valuation and analysis | 주식시장 AI 에이전트